Table 1.
Clinical characteristics of the patients with PE in RHWU cohort.
| BPE (n = 391) | MPE (n = 335) | P | |
|---|---|---|---|
| Age | 57.5 ± 18.0 | 63.5 ± 13.6 | <0.001 |
| Gender, male | 270 (69.1%) | 192 (57.3%) | 0.001 |
| Male | 270(30.9%) | 192(42.7%) | |
| Female | 121 | ||
| Fever | 157 (40.2%) | 54 (16.1%) | <0.001 |
| PE volume | 0.410 | ||
| Mild | 97 (24.8%) | 92 (27.5%) | |
| Moderate | 200 (51.2%) | 168 (50.1%) | |
| Severe | 94 (24.0%) | 75 (22.4%) | |
| Primary site | 0.316 | ||
| Unilateral | 219 (56.0%) | 200 (59.7%) | |
| Bilateral | 172 (44.0%) | 135 (40.3%) | |
| WBC (109/L) | 7.5 ± 2.6 | 7.7 ± 2.3 | 0.570 |
| NC (109/L) | 5.6 ± 1.3 | 5.5 ± 1.9 | 0.788 |
| LC (109/L) | 1.2 ± 0.5 | 1.3 ± 0.7 | 0.375 |
| RDW | 45.2 ± 6.5 | 46.1 ± 7.0 | 0.069 |
| PLT (109/L) | 276.3 ± 118.2 | 263.0 ± 113.0 | 0.122 |
| CRP (mg/L) | 67.8 ± 29.4 | 35.4 ± 18.5 | <0.001 |
| ALP (U/L) | 67.1 ± 20.6 | 70.3 ± 17.6 | 0.321 |
| ALB (g/L) | 60.5 ± 17.3 | 66.7 ± 26.3 | 0.142 |
| LDH (U/L) | 280.2 ± 131.4 | 289.9 ± 147.2 | 0.571 |
| ESR (mm/h) | 65.3 ± 18.6 | 41.4 ± 12.9 | <0.001 |
| CEA (ng/mL) | 3.1 ± 1.7 | 57.3 ± 19.0 | <0.001 |
| SCC (ng/mL) | 1.3 ± 0.6 | 2.4 ± 0.7 | 0.001 |
| NSE (ng/mL) | 20.0 ± 7.7 | 27.1 ± 13.8 | <0.001 |
| Effusion WBC | 1290.0 (445.0, 2739.0) | 1158.0 (480.0, 2100.0) | 0.418 |
| Effusion N% | 20.5 ± 5.1 | 16.9 ± 8.7 | 0.029 |
| Effusion L% | 74.0 ± 26.4 | 74.4 ± 22.0 | 0.842 |
| Effusion ALB | 38.7 ± 13.7 | 40.8 ± 11.9 | 0.028 |
| Effusion ADA | 31.5 ± 11.7 | 14.3 ± 6.1 | <0.001 |
| Effusion LDH | 256.0 (133.0, 501.0) | 301.0 (184.0, 530.0) | 0.293 |
| Effusion CEA | 1.0 (0.5, 1.8) | 168.8 (6.9, 688.0) | <0.001 |